翻訳と辞書 |
Omarigliptin : ウィキペディア英語版 | Omarigliptin
Omarigliptin (MK-3102) is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co. 〔(【引用サイトリンク】 title=Pharmacokinetics of Omarigliptin (Mk-3102), A Once-Weekly Dipeptidyl Peptidase-IV (DPP-4) Inhibitor, in Patients With Renal Impairment )〕 It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels. ==History== MARIZEV (omarigliptin) 25 mg and 12.5 mg tablets were approved by Japanese Pharmaceuticals and Medical Devices Agency or PMDA on 28th Sept 2015. Japan was the first country to have approved omarigliptin.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Omarigliptin」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|